Vericel Corporation (VCEL)
NASDAQ: VCEL · Real-Time Price · USD
36.27
+0.12 (0.33%)
At close: Aug 8, 2025, 4:00 PM
36.24
-0.03 (-0.08%)
After-hours: Aug 8, 2025, 6:22 PM EDT
H&E Equipment Services Revenue
Vericel had revenue of $63.24M in the quarter ending June 30, 2025, with 20.09% growth. This brings the company's revenue in the last twelve months to $249.12M, up 16.13% year-over-year. In the year 2024, Vericel had annual revenue of $237.22M with 20.10% growth.
Revenue (ttm)
$249.12M
Revenue Growth
+16.13%
P/S Ratio
7.23
Revenue / Employee
$697,812
Employees
357
Market Cap
1.83B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 237.22M | 39.71M | 20.10% |
Dec 31, 2023 | 197.52M | 33.15M | 20.17% |
Dec 31, 2022 | 164.37M | 8.18M | 5.24% |
Dec 31, 2021 | 156.18M | 32.01M | 25.77% |
Dec 31, 2020 | 124.18M | 6.33M | 5.37% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
VCEL News
- 10 days ago - Vericel Corporation (VCEL) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Vericel Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 24 days ago - Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025 - GlobeNewsWire
- 2 months ago - Vericel Corporation: Moving From Sell To Neutral - Seeking Alpha
- 2 months ago - Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025 - GlobeNewsWire
- 3 months ago - Vericel Corporation (VCEL) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
- 3 months ago - Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance - GlobeNewsWire
- 3 months ago - Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025 - GlobeNewsWire